| Takano R, Takata N, Shiraki K, et al.
A theoretical-empirical analysis on the initial dissolution rate of drugs from polydispersed particles. [Journal Article]
Biol Pharm Bull 2009 Nov; 32(11):1885-91.
Abstract | Full Citation | | Duval A, Dubertret L
Aprepitant as an antipruritic agent? [Case Reports, Letter]
N Engl J Med 2009 Oct 1; 361(14):1415-6.
Full Citation | Find Related Articles | | Ho H, Yuen C
Aprepitant-associated ifosfamide neurotoxicity. [JOURNAL ARTICLE]
J Oncol Pharm Pract 2009 Sep 16.
Full Citation | Publisher Full Text | Find Related Articles | | Hesketh PJ, Aapro M, Street JC, et al.
Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy. [JOURNAL ARTICLE]
Support Care Cancer 2009 Sep 12.
Abstract | Full Citation | | Curran MP, Robinson DM
Aprepitant: a review of its use in the prevention of nausea and vomiting. [Journal Article]
Drugs 2009; 69(13):1853-78.
Abstract | Full Citation | | Marbury TC, Jin B, Panebianco D, et al.
Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects. [Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Anesth Analg 2009 Aug; 109(2):418-25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kast RE
Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth: a new hypothesis to an old question. [JOURNAL ARTICLE]
Clin Transl Oncol 2009 Jul; 11(7):408-410.
Full Citation | | Rapoport BL, Jordan K, Boice JA, et al.
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study. [JOURNAL ARTICLE]
Support Care Cancer 2009 Jul 1.
Abstract | Full Citation | Find Related Articles | | McCabe C, Cowen PJ, Harmer CJ
NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers. [JOURNAL ARTICLE]
Int J Neuropsychopharmacol 2009 Jun 23.:1-14.
Abstract | Full Citation | Find Related Articles | | Roila F, Rolski J, Ramlau R, et al.
Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting. [JOURNAL ARTICLE]
Ann Oncol 2009 Jun 18.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
